1
14.66 billion. Unfavorable change charges minimize worldwide revenue by 4 percent.
Sales were down sharply for primary care and specialty care medicines and down by a % or two for most cancers medicine and drugs sold in emerging markets akin to China and India.

Comments

Who Upvoted this Story